Skip to main content
. 2022 May 11;127(4):712–719. doi: 10.1038/s41416-022-01828-0

Table 1.

Patients’ characteristics, 2010–2017.

Characteristics N %
Gender
 Female 13,719 52.61
 Male 12,358 47.4
Age
 65–69 1613 6.2
 70–79 9893 37.9
 80–89 10,767 47.3
 90+ 3804 14.6
Cancer site
 Lung 5166 19.8
 Digestive organsa 4360 16.7
 Prostate 2093 8.4
 Hematologicalb 2093 8.0
 Unspecified primary sites 1740 6.7
 Colorectal 1734 6.6
 Breast 1663 6.4
 Urinary tract 1625 6.2
 Pancreatic 1383 5.3
 Female reproductive organs 1129 4.3
 Other 2987 11.4
Charlson Comorbidity Index
 0 6909 26.5
 1–3 14,455 55.4
 4–6 2261 8.7
 7+ 2452 9.4
IMDc 343
 1st (most deprived) 6039 23.2
 2nd 5806 22.3
 3rd 5740 22.0
 4th 4725 18.1
 5th (least deprived) 3767 14.4
Region
 South East Coast 5298 20.3
 South Central 4224 16.2
 North West 4037 15.5
 West Midlands 3359 12.8
 South West 3107 11.9
 London 2882 11.0
 East of England 2172 8.3
 Yorkshire & The Humber 578 2.2
 North East 420 1.6

aDigestive organs included oesophagus, liver, stomach and other digestive organs.

bLymphomas and other haematological neoplasms including hodgin lymphoma, follicular and non-follicular lymphoma, mature T/NK-cell lymphomas, lymphoma T/NK-cell–cell lymphomas, malignant immunoproliferative diseases, multiple myleoma and malignant plasma cell neoplasms, lymphoid leukaemia, myeloid leukaemia, monocytic leukaemia and other leukaemias.

cIMD Index of Multiple Deprivation.